Digoxin Use Is Associated With Reduced Interstage Mortality in Patients With No History of Arrhythmia After Stage I Palliation for Single Ventricle Heart Disease
David W. Brown(Children's Mercy Hospital), Jeffrey Anderson(NOAA National Weather Service), Carole Lannon(University of Maryland, Baltimore), Samuel P. Hanke, Laura E. Peterson(University of Maryland, Baltimore), Eileen King(Cincinnati Children's Hospital Medical Center), Colleen Mangeot(University of Maryland, Baltimore), Steven R. Neish(Baylor College of Medicine), Craig E. Fleishman, Christina Phelps(Nationwide Children's Hospital), Stacey Lihn, Robert H. Beekman(Cincinnati Children's Hospital Medical Center)
Cited by 74
Related Papers
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
|Circulation|2011|848
Brain Volume and Metabolism in Fetuses With Congenital Heart Disease
|Circulation|2009|659
NGAL is an early predictive biomarker of contrast-induced nephropathy in children
|Pediatric Nephrology|2007|459
Spectrum of CHD7 Mutations in 110 Individuals with CHARGE Syndrome and Genotype-Phenotype Correlation
|The American Journal of Human Genetics|2006|393